Yang Li | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Yang Li | Medicine | Best Researcher Award

Shanghai East Hospital, Tongji University School of Medicine | China

Dr. Yang Li is a dedicated postdoctoral researcher at Shanghai East Hospital, affiliated with the Tongji University School of Medicine. With a strong background in internal medicine, he has actively contributed to medical research and patient care. His academic journey is marked by significant achievements, and his work continues to impact the field of clinical medicine, particularly in the areas of metabolic disorders and geriatric health.

Professional profile👤

ORCID

Scopus

Strengths for the Awards✨

  • Strong Academic Background

    • Yang Li has a well-structured academic trajectory, progressing from a Bachelor’s degree in Clinical Medicine to a Postdoctoral position at a reputable institution (Shanghai East Hospital, Tongji University School of Medicine).

    • The M.D. in Internal Medicine and a prior Master’s degree provide a solid foundation for research in this field.

  • Impressive Publication Record

    • Multiple first-author publications in well-regarded medical journals, indicating independent research contributions.

    • Publications focus on crucial areas such as metabolic diseases, multimorbidity, and nephroprotection, showcasing a diverse yet specialized research profile.

    • Collaboration with multidisciplinary teams suggests strong teamwork and networking in the research community.

  • Impactful Research Topics

    • The studies address real-world clinical challenges, including lipid metabolism, diabetes, multimorbidity, and nephroprotection, which have significant implications for patient care.

    • The use of large-scale datasets and real-world analysis enhances the credibility and applicability of findings.

  • Consistency and Productivity

    • Continuous output of publications from 2022 to 2025 demonstrates a sustained research commitment.

    • The ability to conduct retrospective cohort studies and cross-sectional analyses highlights strong methodological expertise.

Education 🎓

Yang Li pursued his higher education at Tongji University, where he earned multiple degrees in clinical and internal medicine:

  • M.D. in Internal Medicine (2020-2023)
  • Master’s Degree in Internal Medicine (2017-2019)
  • Bachelor’s Degree in Clinical Medicine (2011-2017) His academic training has equipped him with in-depth knowledge and expertise in diagnosing and treating complex medical conditions.

Experience 🎉

As a postdoctoral researcher at Shanghai East Hospital, Yang Li has been deeply involved in clinical research, focusing on metabolic health, multimorbidity, and geriatric care. His work bridges the gap between clinical practice and research, aiming to improve patient outcomes through evidence-based findings. His experience spans retrospective cohort studies, cross-sectional analyses, and real-world population-based research.

Research Interest On Medicine 🔬

Yang Li’s research interests include:

  • Metabolic Disorders & Insulin Resistance
  • Geriatric Multimorbidity and Critical Care
  • Cardiometabolic Health & Lifestyle Factors
  • Pharmacological Interventions in Diabetes Management Through his research, he seeks to understand the intricate relationships between metabolic health, aging, and disease prevention.

Awards 🏆

Yang Li has received recognition for his significant contributions to medical research. His work has been acknowledged in the form of grants, academic awards, and invitations to present at international conferences. His research excellence continues to earn him accolades in the scientific community.

Publications 📚

Yang Li has authored multiple impactful publications in peer-reviewed journals. Some of his notable works include:

  • “Sex differences in associations of metabolic inflammation and insulin resistance with incident type 2 diabetes mellitus: a retrospective cohort of adults with annual health examinations”

    • Authors: Yang Li, Xiaotong Guo, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Huixiao Yuan, Shasha Geng, Yue Liu​

    • Publication Year: 2025​

  • “Multimorbidity in elderly patients with or without T2DM: A real-world cross-sectional analysis based on primary care and hospitalisation data”

    • Authors: Yang Li, Shasha Geng, Huixiao Yuan, Jianli Ge, Qingqing Li, Xin Chen, Yingqian Zhu, Yue Liu, Xiaotong Guo, Xiaoli Wang, et al.​

    • Publication Year: 2024​

  • “Nephroprotective effect of SGLT2 inhibitors in elderly patients with type 2 diabetes mellitus and hypertension: a real-world population-based cohort study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Yue Liu, Qingqing Li, Xin Chen, Yingqian Zhu, Xiaotong Guo, Huixiao Yuan, Xiaoli Wang, et al.​

    • Publication Date: November 16, 2024​

  • “Global trends in research related to functional dyspepsia and anxiety or depression over the past two decades: a bibliometric analysis”

    • Authors: Qian Huang, Huixiao Yuan, Qingqing Li, Yang Li, Shasha Geng, Yingqian Zhu, Min Liao, Hua Jiang​

    • Publication Year: 2023​

  • “Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia”

    • Authors: Yingqian Zhu, Xin Chen, Shasha Geng, Qingqing Li, Yang Li, Huixiao Yuan, Hua Jiang​

    • Publication Year: 2023​

  • “Reliability of Risk Assessment for Intra-Hospital Venous Thromboembolism: An Exploratory Cross-Sectional Study”

    • Authors: Shasha Geng, Yang Li, Jianli Ge, Xiaotong Guo, Yue Liu, Hua Jiang​

    • Publication Year: 2023​

  • “Lifestyle-based oxidative balance score and its association with cardiometabolic health of the community-dwelling elderly: A cross-sectional secondary analysis”

    • Authors: Yang Li, Huixiao Yuan, Qingqing Li, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: September 27, 2022​

  • “Circular RNA expression profiles in extracellular vesicles from the plasma of patients with pancreatic ductal adenocarcinoma”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: December 2019​

  • “Using the Risk Factors of Pancreatic Cancer and Their Interactions in Cancer Screening: A Case-Control Study in Shanghai, China”

    • Authors: Yang Li, Qingqing Li, Huixiao Yuan, Shasha Geng, Xin Chen, Yingqian Zhu, Hua Jiang​

    • Publication Date: July 11, 2019​

Conclusion 🏅

Yang Li is an accomplished medical researcher whose work contributes significantly to the field of internal medicine. His dedication to advancing medical knowledge, combined with his expertise in metabolic and geriatric health, underscores his role as a leading researcher in his field. Through his publications and ongoing research, he continues to impact patient care and medical science positively.

Youngji Jo | Medicine | Best Researcher Award

Posted on by sciencefather

Dr. Youngji Jo | Medicine | Best Researcher Award

Assistant Professor | UConn Health | United States

Dr. Youngji Jo is an esteemed researcher and academic with a profound background in public health sciences, epidemiology, and health systems modeling. She currently serves as an Assistant Professor in the Department of Public Health Science at the University of Connecticut (UConn Health), USA. With a wealth of experience in infectious disease modeling, health economics, and digital health, Dr. Jo has made significant contributions to global health research, particularly in tuberculosis (TB), HIV, and COVID-19 studies. Her interdisciplinary expertise bridges epidemiology, policy evaluation, and data-driven decision-making.

Profile👤

ORCID

Scopus

Google Scholar

Strengths for the Awards✨

✅ Outstanding Research Contributions: Dr. Youngji Jo has an extensive research portfolio, with expertise in epidemiology, infectious disease modeling, digital health, and public health interventions. She has made significant contributions to tuberculosis (TB) and HIV/AIDS research, as well as COVID-19 modeling, demonstrating her impact on global health policy and disease control.

✅ Strong Funding and Grant Record: She has secured multiple prestigious grants, including from the NIH (F32 Fellowship), Bill & Melinda Gates Foundation, and Korea Disease Control and Prevention Agency. Her ability to attract competitive funding highlights the recognition of her work in the scientific community.

✅ Interdisciplinary and Global Research Impact: Her work spans multiple countries, including the U.S., South Korea, India, Bangladesh, and Nigeria. She has collaborated with top institutions such as Johns Hopkins University, Boston Medical Center, Korea University, and the WHO, indicating a strong global research network.

✅ Applied and Policy-Relevant Research: Her projects focus on real-world impact, such as cost-effectiveness of public health interventions, mathematical modeling of infectious diseases, and policy development for pandemics. This makes her research highly relevant to public health decision-making.

✅ Recognition and Awards: She has received several competitive scholarships and fellowships, such as the NIH Fellowship, WHO-JHU Global mHealth Initiative Scholarship, and conference awards from the International AIDS Society and CROI, reflecting her academic excellence.

Education 🎓

Dr. Jo earned her Ph.D. in Health Systems from the International Health Department at Johns Hopkins Bloomberg School of Public Health, USA. Her doctoral dissertation focused on the cost-effectiveness and scalability of an mHealth intervention to improve pregnancy surveillance in rural Bangladesh. She further enhanced her expertise with post-doctoral fellowships at Boston Medical Center and Johns Hopkins Bloomberg School of Public Health, specializing in infectious disease modeling and health systems research. She holds an M.A. in International Economics & International Relations from Johns Hopkins School of Advanced International Studies (SAIS) and a B.E. in Electrical Engineering from Seoul National University, South Korea.

Experience 💼

Dr. Jo’s extensive research career includes roles as a Post-Doctoral Fellow at Boston University, where she investigated the intersection of HIV and TB care delivery. She has served as a Research Scientist at the Bill & Melinda Gates Foundation, developing agent-based stochastic TB models. Additionally, she has collaborated with global institutions such as the Korea Disease Control and Prevention Agency, RIGHT Foundation, and WHO, contributing to the development of health technologies, pandemic policy evaluations, and mathematical modeling for infectious diseases.

Research Interests On Medicine 📝

Dr. Jo’s research spans multiple critical areas of public health, including:

  • Infectious disease modeling (TB, HIV, COVID-19)
  • Health economics and cost-effectiveness analysis
  • Digital health interventions and mHealth solutions
  • Global health policy evaluation
  • Big data and artificial intelligence applications in epidemiology

Awards & Honors 🏆

Dr. Jo has received numerous accolades for her contributions to public health research, including:

  • Pre-K Junior Faculty Career Development Award (2022-Present)
  • NIH F32 Individual Fellowship Grant (2020-2022)
  • International AIDS Society Conference Scholarship (2021)
  • Gordis Teaching Fellowship at Johns Hopkins University (2014)
  • WHO-JHU Global mHealth Initiative Scholarship (2012)
  • Japan Student Services Organization (JASSO) Government Scholarship (2005-2006)

Publications 📚

Dr. Jo has published extensively in high-impact journals. Some of her recent publications include:

  • Integrated multi‐month dispensing for HIV and hypertension in South Africa: A model of epidemiological impact and cost‐effectiveness

    • Year: 2025
    • Authors: Youngji Jo, Sydney Rosen, Brooke E. Nichols, Lise Jamieson, Nkgomeleng Lekodeba, Robert Horsburgh, Jr.

  • Nationwide Target Trial Emulation Evaluating the Clinical Effectiveness of Oral Antivirals for COVID-19 in Korea

    • Year: 2024
    • Authors: Kyungmin Huh, Youngji Jo, Gi Hwan Bae, Hyejin Joo, Munkhzul Radnaabaatar, Hyungmin Lee, Jungyeon Kim, Dong-Hwi Kim, Min-Gyu Yoo, Il Uk Jo et al.

  • Antenatal care in rural Bangladesh: current state of costs, content and recommendations for effective service delivery

    • Authors: Y Jo, K Alland, H Ali, S Mehra, AE LeFevre, S Pak, S Shaikh, P Christian, …
    • Year: 2019
    • Citations: 62

  • Using the lives saved tool (LiST) to model mHealth impact on neonatal survival in resource-limited settings

    • Authors: Y Jo, AB Labrique, AE Lefevre, G Mehl, T Pfaff, N Walker, IK Friberg
    • Year: 2014
    • Citations: 59

  • Cost-effectiveness of remdesivir and dexamethasone for COVID-19 treatment in South Africa

    • Authors: Y Jo, L Jamieson, I Edoka, L Long, S Silal, JRC Pulliam, H Moultrie, …
    • Year: 2021
    • Citations: 57

  • Drinking and driving in Vietnam: public knowledge, attitudes, and practices

    • Authors: NT Tran, AM Bachani, VC Pham, JC Lunnen, Y Jo, J Passmore, …
    • Year: 2012
    • Citations: 49

  • Model-based cost-effectiveness of state-level latent tuberculosis interventions in California, Florida, New York, and Texas

    • Authors: Y Jo, S Shrestha, I Gomes, S Marks, A Hill, G Asay, D Dowdy
    • Year: 2021
    • Citations: 37

  • Forecasting the value for money of mobile maternal health information messages on improving utilization of maternal and child health services in Gauteng, South Africa: cost …

    • Authors: A LeFevre, MA Cabrera-Escobar, D Mohan, J Eriksen, D Rogers, …
    • Year: 2018
    • Citations: 26

  • Model-based cost-effectiveness analysis of oral antivirals against SARS-CoV-2 in Korea

    • Authors: Y Jo, SB Kim, M Radnaabaatar, K Huh, JH Yoo, KR Peck, H Park, J Jung
    • Year: 2022
    • Citations: 23

  • Costs and cost-effectiveness analyses of mCARE strategies for promoting care seeking of maternal and newborn health services in rural Bangladesh

    • Authors: Y Jo, AE LeFevre, K Healy, N Singh, K Alland, S Mehra, H Ali, S Shaikh, …
    • Year: 2019
    • Citations: 23

Conclusion 🔖

Dr. Youngji Jo is a distinguished academic and researcher whose interdisciplinary expertise continues to shape the landscape of global public health. Her contributions to infectious disease modeling, health economics, and digital health interventions have significantly advanced our understanding of TB, HIV, and COVID-19. As she continues her research at UConn Health, her work remains at the forefront of data-driven solutions for global health challenges.